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The global phenomenon of antibioresistance, resistance genes
pool (clinical and environmental reservoirs), and envi-
ronmental pollution, especially by xenobiotics, including
antibiotics which are considered water micropollutants, are
acknowledged as some of the most important problems the
world is facing today [1]. Thus, the necessity of antimicrobial
agents that are new, efficient, non-toxic, and with no selective
pressure activity is obvious.
Despite the huge scientific progress in vaccination and
chemotherapy, infectious diseases remain a serious health
issue. Under the selective pressure of therapeutical antibi-
otics, used excessively during the last decades, some bacterial
species/strains harboring resistance genes (pre-existent to
antibiotherapy) were selected and disseminated, developing
other mechanisms of resistance. As a consequence, infectious
diseases remain among the leading causes of morbidity
worldwide and a top priority for the public health. However,
little progress has been made in the development of new
antimicrobial drugs. Moreover, the wide use of antibiotics
has evolutionary and ecological effects, leading to the recruit-
ment of more genes into the resistome and mobilome, with
adverse consequences for human welfare and environment
[2, 3]. There are also a lot of biofilm-associated infections
and the biofilm embedded cells show a different form of
resistance, called now tolerance. Biofilms cause great medical
concerns, as they may be developed on medical devices,
tissues, and organs (normal or damaged), but also industrial
problems, since they could be formed on any device and
industrial equipment. Microorganisms attached to a substra-
tum and organized in biofilms exhibit a high tolerance to
the current antibiotics, antiseptics, and biocides, as well as
to the host defense mechanisms. Moreover, the resistance
and virulence genes are easily achieved between biofilm’s
embedded cells by horizontal transfer, due to their proximity
[4].
In the industrial environment, current anti-fouling agents
are also far frombeing efficient.Hence, the adherentmicroor-
ganisms on surfaces produce great economical losses caused
by the uncontrolled development of biofilms on pharma-
ceutical or food industrial equipment. Therefore, numerous
industrial technologies have to make a difficult choice: either
to utilize a high amount of an efficient anti-fouling agent
with the risk of developing side effects and impurifications
on the final product or not to be able to control the
microbial contamination and biofilmdevelopmentwithin the
technological processes. In these conditions, new, safe for
health (without cytotoxicity), and eco-friendly biocides are
necessary, because the consumers are currently informed,
show great interest, and demand healthy food. In the coming
years, it is estimated that the EU regulations will be changed
and certain biocides will be banned, due to their biohazard
effects.
Considering the high frequency of genetic antibioresis-
tance in the most common pathogens, the huge public health
burden of severe biofilm-associated infections (60–80% of
all infections), and the great economical loses caused by
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the uncontrolled development of biofilms on industrial
equipment, alternative strategies are urgently needed to
efficiently control their formation and their negative effects.
Thus, the researchers are in a continuous quest for new
antibacterial agents for resistant/multiresistant strains, able
to penetrate the biofilms and with activity on adherent
cells. Innovative approaches include the following: (1) the
development of prophylactic antimicrobial peptides, able to
interfere with the intercellular communication by quorum-
sensing (QS) mechanism, involved in regulation of a series of
genes, including virulence genes; such QS inhibitors (QSIs)
belong to the antipathogenic strategies [5]; (2) enzymes
able to degrade biofilm’s matrix (dispersins) or the signal
molecules (quenching enzymes). To date, none of the envis-
aged antibiofilm solutions has an absolute outcome, but only
their combinations seem to be effective.
The use and abuse of antibiotics, especially those with
large spectrum of activity, are the cause of the frequent con-
dition of disbiosis or alteration of the intestinal microbiota’s
interspecific equilibrium. Such conditions are leading to
opportunistic infections, metabolic disturbances, increased
intestinal permeability, and chronic inflammation. Evidence
obtained by animal models and clinical studies confirm the
association of an altered gut microbiota with all corollary
consequences, such as metabolic diseases from obesity to
type-2 diabetes, tooth decay, cardiovascular diseases, and
cancer [6].
All these recently high increased problems have cat-
alyzed the research efforts to find new ways to fight against
pathogens, with no side effects on the host and its normal
microbiota, but also on the environment. A lot of studies
are now focused on the investigation of bioactive natural
products (BIONPs), mainly obtained from plants with a
very wide range of biological activities: antimicrobial, anti-
inflammatory, antioxidant, immunomodulatory, antidepres-
sant, antihyperglycaemic (amylase activity), antihyperten-
sive, anticarcinogenic, etc. These BIONPs are used as plant
extracts or fractions, coupled or not with carriers (nanopar-
ticles). Medicinal plants have now to be investigated at
molecular level, in order to identify themechanisms of action,
efficiency, and lack of cytotoxicity, since their use has to be
scientifically based, in definite amounts and for a specific
target, in comparison with the allopathic drugs.The potential
synergistic activity with antibiotics should be also explored
[7, 8].
Thus, plants are an important source of BIONPs; all
plants have immune defense mechanisms mediated by anti-
infectious phytocompounds, such as phytoanticipins and
phytoalexins and the more recently described QSIs.The QSIs
exhibit, when used even in subinhibitory concentrations, an
indirect antimicrobial effect, manifested by inhibiting the
bacterial intercellular communication by QSmechanism and
coordinated expression of virulence genes depending on
cellular density. The use of QSIs could represent an efficient
and intelligent strategy to control resistance/tolerance, viru-
lence, and colonization/biofilm formation, without selective
pressure and other side effects [5, 9–13].
However, the use of BIONPs has some limitations, due to
their low availability and stability, high volatility, and a great
diffusion ability that do not recommend their implementa-
tion in the currentmedical practice.These features lead to the
necessity of developing vectorization and delivery agents for
improving their efficiency and also optimized assay methods
adapted for their specific properties. However, the research
efforts are fully justified by their great potential.
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